Printer Friendly

Omron Healthcare unveils the Avail wireless TENS device for drug-free relief from chronic and acute pain.

M2 EQUITYBITES-January 10, 2018-Omron Healthcare unveils the Avail wireless TENS device for drug-free relief from chronic and acute pain

(C)2018 M2 COMMUNICATIONS http://www.m2.com

Heart health company Omron Healthcare Inc announced on Tuesday the availability of the innovative over-the-counter medical device for safe and effective drug-free pain relief, the Avail.

The company said Avail is its first TENS (Transcutaneous Electrical Nerve Stimulation) unit with wireless and dual channel capability that provides relief from chronic and acute pain. The device can treat multiple pain sites simultaneously and is controlled by its new mobile app, Omron TENS, enabling users to operate Avail remotely.

According to the company, the Avail wireless TENS device includes two soft, contoured pads that fit comfortably and securely to treat a variety of areas of pain simultaneously. Users can choose from pre-programmed therapies or design their own.

Additionally, Avail's five pre-programmed Body Pain Modes soothe lower back, shoulder, knee, elbow and leg pain with recommended therapies. Avail users can design their own therapies using five additional pulsation modes, including steady, acupuncture-like, knead, tap and microcurrent and 20 different intensity levels. The bluetooth connectivity provides wireless control of settings via the Omron TENS app, for on-the-go personal control of pain relief, added the company.

In conjunction, the Omron Avail device, which has received US FDA clearance, is available for purchase at Omronhealthcare.com for USD199.99. Those who purchase now may take advantage of the introductory pricing offer of USD159.99 through 31 March 2018, concluded the company.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 10, 2018
Words:263
Previous Article:Seaspan announces common and preferred stock dividends for quarter.
Next Article:Preferred Apartment acquires multifamily community in Florida.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters